MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202411004519 A) filed by Shoolini University Of Biotechnology And Management Sciences, Solan, Himachal Pradesh, on Jan. 23, 2024, for 'nano-based drug delivery system for antifngal infection and method for preparing same.'
Inventor(s) include Shikha Mahant; and Deepak Kapoor.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present invention discloses a nano-based drug delivery system for antifungal infections. The present formulation comprising of a pharmaceutical active ingredient which is selected from 100 mg of metronidazole and 200 mg of miconazole nitrate or its combination, the lipid component is 2-4% of phospholipon 90G, the surfactant is 1-3% tween 80, and the penetration enhancer is chloroform and methanol in a ratio of 2:1. In the earlier formulations the ability of these formulations is often limited by poor drug penetration and short residence time. In present invention, the inventors aimed to develop and evaluate a novel drug delivery system for the management of vaginal infections whereas, gel exhibits a property which including but not limited to enhanced drug permeation, retention, and improved therapeutic efficacy."
Disclaimer: Curated by HT Syndication.
